Predictive Efficacy of Low Burden EGFR Mutation Detected by Next-Generation Sequencing on Response to EGFR Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Carcinoma

類似資料

• EGFR endocytosis is a novel therapeutic target in lung cancer with wild-type EGFR
  著者:: Jo, Ukhyun, 等
  出版事項: (2014)
• Amelioration of Hypercholesterolemia by an EGFR Tyrosine Kinase Inhibitor in Mice with Liver-Specific Knockout of Mig-6
  著者:: Lee, Jun Choul, 等
  出版事項: (2014)
• EGFR Mutation Status in Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Efficacy of EGFR Tyrosine Kinase Inhibitors
  著者:: Yang, Jiyoul, 等
  出版事項: (2018)
• Quantification of epidermal growth factor receptor (EGFR) mutation may be a predictor of EGFR‐tyrosine kinase inhibitor treatment response
  著者:: Park, Ha Young, 等
  出版事項: (2016)
• Discovery and Evaluation of Polymorphisms in the AKT2 and AKT3 Promoter Regions for Risk of Korean Lung Cancer
  著者:: Sung, Jae Sook, 等
  出版事項: (2012)